DB14931InvestigationalNucleic Acid Based Therapies
Cobomarsen is under investigation in clinical trial NCT02580552 (Safety, Tolerability and Pharmacokinetics of MRG-106 in Patients With Mycosis Fungoides (MF), CLL, DLBCL or ATLL).
- Code names
- MRG-106
Resolves to
Compound
What you can answer from here — as of April 23, 2025
Which companies are running trials of Cobomarsen, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account